Finance

Lists
OSE:EPA
Ose Immunotherapeutics SA
1,81 €
-1,36%
(-0,025) 1D
4 ნოე, 14:23:03 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for OSE...
Open
1,85 €
High
1,85 €
Low
1,80 €
Mkt. cap
42,53 მლნ.
Avg. vol.
179,66 ათ.
Volume
61,90 ათ.
52-wk high
5,92 €
52-wk low
1,80 €
EPS
-1,69 €
Shares outstanding
23,56 მლნ.
No. of employees
64
Open
1,85 €
High
1,85 €
Low
1,80 €
Mkt. cap
42,53 მლნ.
Avg. vol.
179,66 ათ.
Volume
61,90 ათ.
52-wk high
5,92 €
52-wk low
1,80 €
EPS
-1,69 €
Shares outstanding
23,56 მლნ.
No. of employees
64
News stories
From web sources and news partners
FinancialContent
FinancialContent
·
1 საათის წინ
OPENLANE’s (NYSE:OPLN) Q3 2026: beats on revenue
Yahoo Finance
Yahoo Finance
·
17 წუთის წინ
60% of S&P 500 Stocks Are in a Bear Market, With the Index Near a Record
The Lufkin Daily News
The Lufkin Daily News
·
1 საათის წინ
Wall St futures jump as Democrats sweep midterms
The Motley Fool
The Motley Fool
·
16 წუთის წინ
Meet the Only "Magnificent Seven" Stock That's Outperforming the S&P 500 and Nasdaq This Year (Hint: It's Not Nvidia)
About Ose Immunotherapeutics SA
CEO-
Employees64
Founded17 ნოე. 2004
Headquarters-
Sector-
Industry-
Websiteose-immuno.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
სექ. 2024
დეკ. 2024
Revenue
431,00 ათ.
431,00 ათ.
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
8,28 მლნ.
8,28 მლნ.
Total research and development expenses
-
-
Selling, general, and admin expenses
1,08 მლნ.
1,08 მლნ.
Operating expense
10,22 მლნ.
10,22 მლნ.
Total operating expenses
10,22 მლნ.
10,22 მლნ.
Operating income
-9,79 მლნ.
-9,79 მლნ.
Other non operating income
-611,00 ათ.
-611,00 ათ.
EBT including unusual items
-10,44 მლნ.
-10,44 მლნ.
EBT excluding unusual items
-10,53 მლნ.
-10,53 მლნ.
Income tax expense
-576,50 ათ.
-576,50 ათ.
Effective tax rate
5,52%
5,52%
Other operating expenses
41,00 ათ.
41,00 ათ.
Net income
-9,86 მლნ.
-9,86 მლნ.
Net profit margin
-2 288,86%
-2 288,86%
Earnings per share
-
-
Interest and investment income
571,00 ათ.
571,00 ათ.
Interest expense
-707,50 ათ.
-707,50 ათ.
Net interest expenses
-136,50 ათ.
-136,50 ათ.
Depreciation and amortization charges
-
-
EBITDA
-9,74 მლნ.
-9,74 მლნ.
Gain or loss from assets sale
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები